The Greater Intermountain Node
The Greater Intermountain Node
The Greater Intermountain Node (GIN) was founded in 2019 to expand the existing National Institute of Drug Abuse Clinical Trial Network (CTN) infrastructure by developing and testing innovative interventions for opioid use disorder, preventing overdose, expanding the settings for Network research, and bringing new research expertise of opioid addiction research to the Utah, regional, and national communities.
ABOUT THE GREATER INTERMOUNTAIN NODE
The Greater Intermountain Node (GIN) is housed within the Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) at the University of Utah. The GIN brings particular expertise in three areas of opioid addiction research to the Utah, regional, and national communities:
- Research within non-addiction specialty health care settings
- Research with communities of persons with vulnerability
- Health service/care policies
The GIN leverages robust institutional commitment and infrastructure, institutional centers focused on addiction-related research, and training programs with strong regional and national connections to clinicians, educators, other institutions and organizations, and community stakeholders.
OUR CTN RESEARCH
Adam Gordon, MD, MPH
Dr. Adam Gordon is the Elbert F. and Marie Christensen Endowed Research Professor, tenured Professor of Medicine and Psychiatry, at the University of Utah School of Medicine and the Section Chief of Addiction Medicine at the VA Salt Lake City Health Care System. Dr. Gordon has a 20+ year track record of conducting research on the quality, equity, and efficiency of health care for vulnerable populations, including those who are homeless or who have addiction.
Gerald Cochran, PhD, MSW
Dr. Gerald Cochran is a Professor in the Department of Internal Medicine, Division of Epidemiology at the University of Utah and also has an adjunct Associate Professor appointment with the University of Utah Department of Psychiatry and is core faculty with the Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center of Innovation within the VA Salt Lake City Health Care System.
Kristi Carlston
Kristi has ten years of progressive research experience that includes design, implementation and management of clinical research projects in an academic setting. She received her bachelor's at the University of Utah in Health Promotion and is certified as a Clinical Research Coordinator through the Association of Clinical Research Professionals. She is responsible for coordination support to study investigators, staff and data management on several multi-site projects.
On the Rocks
On the Rocks is the Greater Intermountain Node's (GIN) monthly Research Discussion Series that highlights the exceptional addiction related research happening in the Greater Intermountain Community. On the Rocks allows for interactive discussion between speakers and attendees to collaborate and share ideas about study expansion and insight.
Learn more about the On the Rocks seminar series below.
YEAR I: 2019-2020
YEAR III: 2021-2022
YEAR IV: 2022-2023
YEAR V: 2023-2024
SIGN UP TO GET OUR EMAILS
For the best way to stay up to date with our node, join our email listsev. Emails include invites to upcoming seminars, grant opportunities, job openings, and more!
DATA SCIENCE
Data is everywhere and expansive. Incorporating data science as a new tool for the study of substance use disorders can be leveraged to reveal new aspects of addiction biology and treatment.
Learn more about the data science initiatives happening here at the Greater Intermountain Node.
Affiliate Faculty
Amanda Allshouse, MS
Amy Butz, PharmD
Alyrene Dorey, MD
A. Taylor Kelley, MD, MPH, MS
Ami Stuart, PhD, MA, MS
Ana Holtey, DO
Audrey Jones, PhD
Ben Brintz, PhD, MS
Billinda Tsuya, PA-C
Brian C. Sauer, PhD, MS
Christina L. Gallop, MD
Danielle Babbel, MD
Daniel W. Odell, MD
Eric L. Garland, PhD, LCSW
Elizabeth Howell, MD, MS
Emily Spivak, MD, MHS
Eamonn Kennedy, PhD, MS
Grace LaFluer, PharmD
Jake S. Magel, PhD, DSc, MSPT
Jasmin E. Charles, PA-C, MPAS
Jeremy E. Thueson, MD
John W. Gardner, PharmD
Julia Lewis, DO
Julie Day, MD
Julie M. Fritz, PhD, PT, ATC
Ken B. Johnson, MD, MS
Kristina Lisa Allen-Brady, PhD, MSPH, BA, MPT
Kristine A. Campbell, MD, MSc
Marcela C. Smid, MD, MA, MS
Mary Jo Pugh, PhD, RN
Mathew Mulligan, MD
Matthew H. Samore, MD
Megan E. Vanneman, PhD, MPH
Michael A. Incze, MD, MSEd
Michelle Debbink, MD, PhD
Molly B. Conroy, MD, MPH, FACSM, FAHA
Natalie Valentino, PharmD
Nasser Sharareh, PhD
Nicholas Cox, PharmD, BCACP
Peter P. Taillac, MD
Rana Jawish, MD
Richard Nelson, PhD, MA, MS
Scott R. Junkins, MD
Troy E. Madsen, MD, FACEP
OTHER NODES
CONTACT US:
Mailing Address:
383 Colorow Drive, Mailbox 16
Salt Lake City, Utah 84108
Email:
Phone:
(801) 213-0806
PARCKA
The Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) promotes and provides addiction related research, clinical care, knowledge and advocacy across the University of Utah, the local community, the state, and the nation.
NIDA Clinical Trials Network
The National Institute of Drug Abuse (NIDA) Clinical Trial Network (CTN) provides an enterprise in which NIDA, treatment researchers, and community-based service providers work toward new treatment options in community-level clinical practice.
